首页> 外国专利> These new antibodies and Fab theta P alpha, sigma, alpha, tau, alpha, ntau, alpha, gamma, Omega, and GPVI are used.

These new antibodies and Fab theta P alpha, sigma, alpha, tau, alpha, ntau, alpha, gamma, Omega, and GPVI are used.

机译:使用了这些新抗体和Fab theta P alpha,sigma,alpha,tau,alpha,ntau,alpha,γ,Omega和GPVI。

摘要

The present invention discloses a new antibody to the additional protein, especially human platelet glycoprotein (GP), and a new antibody to the protein, mu____VI. Fragments or derivatives of epsilon. The cloning of antibodies and antibody fragments of the present invention_beta p_delta u alpha 390 can reduce GPVI induced phenotype.These antibodies and Fab fragments can prevent collagen from docking, thereby inhibiting platelet activation. Whether it's collagen. The present invention also refers to the cloning of the plasmid_beta p_delta u a_and the production and fragmentation of the expressed Fab antibody.The present invention relates to the study, diagnosis and application of antibodies to further break mu__theta__in the United States on Friday It is used to treat thrombosis and other vascular diseases.The invention also relates to a bearing, a method of Fab molecule at C-terminal, and a method for preventing the use of Fab antibody recognition. Such an improved fab. The invention relates to a method to prevent platelet activation when using an anti GPVI wafer fab.
机译:本发明公开了针对另外的蛋白质,特别是人血小板糖蛋白(GP)的新抗体,以及针对蛋白质mu___VI的新抗体。 ε的片段或衍生物。克隆本发明的抗体和抗体片段_beta p_delta u alpha 390可以减少GPVI诱导的表型。这些抗体和Fab片段可以防止胶原蛋白对接,从而抑制血小板活化。无论是胶原蛋白。本发明还涉及质粒βpδ的克隆以及表达的Fab抗体的产生和片段化。用于治疗血栓形成和其他血管疾病的方法。本发明还涉及轴承,在C端的Fab分子的方法以及防止使用Fab抗体识别的方法。这样改进的晶圆厂。本发明涉及一种在使用抗GPVI晶片制造厂时防止血小板活化的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号